failure to respond or late response
on 09 Mar 2003
Last Applicant/ Owned by
Fleet Road
London NW3 2EZ
GB
Serial Number
75913519 filed on 09th Feb 2000
Registration Number
N/A
Correspondent Address
Donna J. Bunton
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, PROTEINS, PEPTIDES, AMINO ACIDS AND THEIR DERIVATIVES, NAMELY, ANTIBODIES AND FRAGMENTS THEREOF; CYTOKINES AND DERIVATIVES OR FRAGMENTS THEREOF, NAMELY, THE INTERLEUKINS (IL), ESPECIALLY THE IL-IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-b AND IL-li SUBTYPES THEREOF; COLONY STIMULATING FACTORS, NAMELY,GRANULOCYTE-MACROPHAGE Read More
POLYMER DERIVATIVES AND POLYETHYLENE GLYCOLDERIVATIVES FOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOLDERIVATIVES FOR USE IN THE MANUFACTURE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES; POLYMERBEADS FOR USE IN MANUFACTURING; POLYALKYLENE GLYCOLSFOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS AND AS IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; LIPOSOMES, PROTEINS AND PEPTIDES FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; DIAGNOSTIC AGENTS AND REAGENTS FOR MEDICAL RESEARCH USE; POLYMER MODIFIED COMPOUNDS FOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS; IMAGING AGENTS FOR DIAGNOSTIC PURPOSES
COSMETIC AND TOILETRY PRODUCTS CONTAINING POLYMER1~-DERIVATIVES; NAMELY, EAU DE COLOGNE, PERFUMES, SHAVING SOAP, TALCUM POWDER, DENTIFRICES, TOOTHPASTE, ESSENTIAL OILS FOR PERSONAL USE, BATH OILS AND BATH SALTS,DEODORANTS FOR PERSONAL USE, SOAPS, SKIN CREAMS AND SKIN LOTIONS, MOISTURIZING CREAMS, BODY LOTIONS, AFTERSHAVE, LIPSTICK, MASCARA, EYELINER, SKIN CLEANSERS,MAKE-UP POWDERS AND CREAMS; NAIL POLISH; HAIRCAREPRODUCTS, NAMELY, HAIR SHAMPOO, CONDITIONER AND GEL;HAIR COLORANTS AND HAIR SPRAYS; MOUSSES AND BALMS FOR HAIR STYLING AND HAIR CARE
PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, PROTEINS, PEPTIDES, AMINO ACIDS AND THEIR DERIVATIVES, NAMELY, ANTIBODIES AND FRAGMENTS THEREOF; CYTOKINES AND DERIVATIVES OR FRAGMENTS THEREOF, NAMELY, THE INTERLEUKINS (IL), ESPECIALLY THE IL-IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-b AND IL-li SUBTYPES THEREOF; COLONY STIMULATING FACTORS, NAMELY,GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR,GRANULOCYTE-COLONY STIMULATING FACTOR (ALPHA AND BETA FORMS) AND MACROPHAGE-COLONY STIMULATING FACTOR (ALSO KNOWN AS CSF-1); HAEMOPOIETINS, NAMELY, ERYTHROPOIETIN,HAEMOPOIETIN-ALPHA AND KIT-LIGAND (ALSO KNOWN AS STEMCELL FACTOR OR STEEL FACTOR); INTERFERONS (IFNS), NAMELY,IFNALPHA, IFNBETA, IFNGAMMA; GROWTH FACTORS ANDBIFUNCTIONAL GROWTH MODULATORS, NAMELY, EPIDERMAL GROWTH FACTOR, PLATELET-DERIVED GROWTH FACTOR,TRANSFORMING GROWTH FACTOR (ALPHA AND BETA FORMS),AMPHIREGULIN, SOMATOMEDIN-C, BONE GROWTH FACTOR,FIBROBLAST GROWTH FACTORS, INSULIN-LIKE GROWTH FACTORS,HERAPIN BINDING GROWTH FACTORS AND TUMOR GROWTH FACTORS; DIFFERENTIATION FACTORS AND THE LIKE, NAMELY,MACROPHAGE DIFFERENTIATING FACTOR, DIFFERENTIATION INDUCING FACTOR (DIF) AND LEUKEMIA INHIBITORY FACTOR;ACTIVATING FACTORS, NAMELY, PLATELET ACTIVATING FACTOR;COAGULATION FACTORS SUCH AS FIBRINOLYTIC/ANTICOAGULANT AGENTS INCLUDING HERAPIN AND PROTEASES AND THEIR PRO-FACTORS, NAMELY, CLOTTING FACTORS VII, VIII, IX, X, XI, XII, ANTITHROMBIN III, PROTEIN C, PROTEIN 5, STREPTOKINASE, UROKINASE, PROUROKINASE, TISSUE PLASMINOGEN ACTIVATOR, FIBRINOGEN AND HIRUDIN; PEPTIDE HORMONES, NAMELY, INSULIN AND CALCITONIN; ENZYMES, NAMELY, SUPEROXIDE DISMUTASE, GLUCOCEREBROSIDASE, ASPARAGINASE AND ADENOSINE DEAMINASE; TRANSCRIPTION FACTORS AND TRANSCRIPTIONAL MODULATORS; CARBOHYDRATES, GLYCOSOAMINOGLYCANS, GLYCOPROTEINS AND POLYSACCHARIDES; LIPIDS, NAMELY, PHOSPHATIDYL-ETHANOLAMINE, PHOSPHATIDYLSERINE AND DERIVATIVES THEREOF; SPHINGOSINE; STEROIDS, NAMELY, CHOLESTEROL AND DERIVATIVES THEREOF; NUCLEOTIDES, NUCLEOSIDES, HETEROCYCLIC BASES, DNA, RNA, SYNTHETIC AND NON-SYNTHETIC OLIGONUCLEOTIDES INCLUDING THOSE WITH NUCLEASE RESISTANT BACKBONES; VITAMINS; ANTIBIOTICS; BACTERISTATIC AND BACTERICIDAL AGENTS; ANTIFUNGAL, ANTHELMINTHIC AND OTHER AGENTS EFFECTIVE AGAINST INFECTIVE AGENTS INCLUDING UNICELLULAR PATHOGENS; SMALL EFFECTOR MOLECULES, NAMELY, NORADRENALIN, ALPHA ADRENERGIC RECEPTOR LIGANDS, DOPAMINE RECEPTOR LIGANDS, HISTAMINE RECEPTOR LIGANDS, GABAIBENZODIAZEPINE RECEPTOR LIGANDS, SEROTONIC RECEPTOR LIGANDS, LEUKOTRIENES AND TRIIODOTHYRONINE; CYTOTOXIC AGENTS SUCH AS DOXORUBICIN, METHOTREXATE AND DERIVATIVES THEREOF; VACCINES, NAMELY, HEPATITIS-B VACCINE, MALARIA VACCINE, MELANOMA VACCINE AND HIV-1 VACCINE
CATHETERS; STENTS AND PARTS AND FITTINGS FOR THESE GOODS
RESEARCH AND CONSULTANCY SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMERTECHNOLOGY IN MEDICINE; LICENSING OF INTELLECTUAL PROPERTY, NAMELY, TECHNOLOGY LICENSING SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY
No 75913519
No Service Mark
No 550-171
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
09th Mar 2003 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
16th Jul 2002 | INQUIRY AS TO SUSPENSION MAILED |
18th May 2001 | LETTER OF SUSPENSION MAILED |
17th Jan 2001 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
17th Jul 2000 | NON-FINAL ACTION MAILED |
03rd Jul 2000 | ASSIGNED TO EXAMINER |
28th Jun 2000 | ASSIGNED TO EXAMINER |